Skip to Content

QNASL Side Effects

Generic Name: beclomethasone nasal

Note: This page contains side effects data for the generic drug beclomethasone nasal. It is possible that some of the dosage forms included below may not apply to the brand name QNASL.

It is possible that some side effects of QNASL may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.

For the Consumer

Applies to beclomethasone nasal: nasal aerosol liquid, nasal aerosol powder, nasal spray

As well as its needed effects, beclomethasone nasal (the active ingredient contained in QNASL) may cause unwanted side effects that require medical attention.

If any of the following side effects occur while taking beclomethasone nasal, check with your doctor immediately:

More common
  • Chills
  • dizziness
  • fast heartbeat
  • lightheadedness
  • rapid, shallow breathing
  • rash
  • unusual bleeding or bruising
Less common
  • Change in vision
  • eye pain
  • headache
  • nausea or vomiting
  • tearing
  • unexplained nosebleeds
Incidence not known
  • Bloody mucus
  • cough or hoarseness
  • difficulty with breathing
  • dizziness
  • hives or welts, itching
  • loss of taste and smell
  • sores inside the nose

For Healthcare Professionals

Applies to beclomethasone nasal: nasal aerosol with adapter, nasal spray


The most commonly reported side effects were epistaxis, nasal discomfort, throat irritation, and headache.[Ref]


Postmarketing reports: Hypersensitivity reactions (including anaphylaxis, angioedema, rash, urticaria, and bronchospasm)[Ref]


Common (1% to 10%): Epistaxis, nasal discomfort, sneezing attacks, nasal stuffiness, rhinorrhea
Frequency not reported: Nasal ulcerations, dryness and irritation of the nose and throat
Postmarketing reports: Nasal septal perforation
Rare (less than 0.1%): Wheezing[Ref]


Frequency not reported: Hypercorticism, adrenal suppression, growth reduction in children[Ref]


Common (1% to 10%): Nausea[Ref]

Nervous system

Common (1% to 10%): Headache, lightheadedness
Postmarketing reports: Loss of taste and smell, unpleasant taste and smell[Ref]


Frequency not reported: Candida albicans infection, immunosuppression[Ref]


Common (1% to 10%): Tearing eyes
Postmarketing reports: Glaucoma, cataracts
Rare (less than 0.1%): Increased intraocular pressure[Ref]


Frequency not reported: Impaired wound healing[Ref]


1. Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0

2. "Product Information. Qnasl (beclomethasone nasal)." Teva Pharmaceuticals USA, North Wales, PA.

3. Cerner Multum, Inc. "Australian Product Information." O 0

4. "Product Information. Beconase AQ (beclomethasone nasal)." GlaxoSmithKline, Research Triangle Park, NC.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.